Alright, here we go: As I have just stated in a message to

New Post Public Reply Private Reply Replies (4) Message Board
patientgal

Alright, here we go:

As I have just stated in a message to a very wise and savvy fellow investor, the best laid plans of Mice & Men...(you know the rest). Due to the very taxing day I have had, my wee summary from last nights conference is officially delayed.

HOWEVER, I am delighted to report that I have recently completed an 18 minute 57 second conversation with our beloved company, Bio-Matrix Scientific Group. I will not disclose to whom I spoke except to say that it was not Dr. Ichim, who is presently dealing with some personal matters, this time (you can read between the below listed lines to come up with your own conclusion. You'll probably be right. Unless of course you are a naysayer and conclude I spoke to no one. In which case you are very much wrong).

I want to reiterate that if the IND application for HemaXellerate had been denied, we would have known by now. BY LAW, the company is required to divulge such. Further, if you look closely at the filings coupled with taking into consideration the money that has been required to see the recent events come to fruition, you will understand that David Koos, the CEO, has had to use his own funds to see this little engine that could keep on moving.

That said, during my conversation with the company I made the sentiments of the investors very clear. Particularly at this juncture where, if for no other reason common courtesy, a PR is overdue. I also outlined for the company various attempts by shorter's and basher's to defame the company by way of disseminating erroneous information about the company. I have no doubt that this was unknown to the company and that the company now understands very well just how vulnerable to these wretched folks they have become.

In conclusion, I was assured that a PR is forthcoming. Of course I was not told when as this would be insider trading but I did emphasize the need for it being without much delay, if any at all. And as I have already stated, my ex's will tell you, I am a lot of things, but a liar and a crook I am not. I did not ask for a definitive.

So, if you sold because you lost faith in this little engine that could, I feel for you. Personally, I am buying more tomorrow.

Folks, I am spent. It has been a long day for PG. Perhaps before I hit the road in the morn', I will be able to summarize the monetary possibilities for this company. It really is staggering.

Oh, and I will be posting this on iHub. But, I think I have to do a little bit of editing to ensure it is not deleted. Feel free to reply to it periodically to keep it high on the board for the newbies to read.

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Experience Culinary Excellence at Hong Kong Wine & Dine Festival

Updated Category News Views 226

Hong Kong Wine & Dine Festival Returns This October HONG KONG, an anticipated gastronomic spectacle is set for the latter part of October. The Hong Kong Wine & Dine Festival will take place from 23 to 26 October 2025 at the iconic Central Harbourfront. This annual celebration is designed to showcase the best in culinary arts and exquisite wines, offering something special...

Continue Reading
Danaher Announces Upcoming Earnings Conference Details

Updated Category News Views 44

Danaher Sets Date for Q3 2024 Earnings Conference Call Danaher Corporation (NYSE: DHR) has announced the date for its highly anticipated quarterly earnings conference call. This event is significant for investors and stakeholders who keep a close eye on the company's developments. Earnings Call Details The earnings call is set for an upcoming Tuesday morning, during which...

Continue Reading
UniQure's Stock Climbs to Record Levels, Eyes Future Growth

Updated Category News Views 67

UniQure Stock Reaches New Heights UniQure NV (QURE) has exciting news as its stock recently touched an impressive 52-week high of $18.5. This remarkable milestone is a testament to the company's resilient growth strategy and innovative advancements in the biotechnology industry. With a market capitalization reaching $885 million, the stock has seen an astonishing rise of...

Continue Reading
MedCana's Colombian Subsidiary Partners with Australian Firm

Updated Category News Views 34

MedCana Enters Negotiations for Cannabis Supply Agreement MedCana, a prominent player in the pharmaceutical-grade cannabis landscape, is making headlines with an exciting new development from its subsidiary in Colombia. The company is set to negotiate a substantial supply agreement worth between $1.2 million and $2.4 million annually. This agreement marks a significant...

Continue Reading
Mouawad and OCTA Properties Launch Luxurious Residences

Updated Category News Views 144

Mouawad Teams Up with OCTA Properties for Luxe Residences OCTA Properties has been selected as the global licensee for residences branded by Mouawad, bringing the brand's legacy of timeless elegance into the realm of premium real estate. This partnership marks an exciting new chapter in Mouawad's prestigious journey in luxury development. A Landmark Collaboration Mouawad,...

Continue Reading